Literature DB >> 11799182

Structure of equine infectious anemia virus matrix protein.

Hideki Hatanaka1, Oleg Iourin, Zihe Rao, Elizabeth Fry, Alan Kingsman, David I Stuart.   

Abstract

The Gag polyprotein is key to the budding of retroviruses from host cells and is cleaved upon virion maturation, the N-terminal membrane-binding domain forming the matrix protein (MA). The 2.8-A resolution crystal structure of MA of equine infectious anemia virus (EIAV), a lentivirus, reveals that, despite showing no sequence similarity, more than half of the molecule can be superimposed on the MAs of human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV). However, unlike the structures formed by HIV-1 and SIV MAs, the oligomerization state observed is not trimeric. We discuss the potential of this molecule for membrane binding in the light of conformational differences between EIAV MA and HIV or SIV MA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11799182      PMCID: PMC135893          DOI: 10.1128/jvi.76.4.1876-1883.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  The NH2-terminal sequence of the avian oncovirus gag precursor polyprotein (Pr76gag).

Authors:  R D Palmiter; J Gagnon; V M Vogt; S Ripley; R N Eisenman
Journal:  Virology       Date:  1978-12       Impact factor: 3.616

2.  Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.

Authors:  A Nicholls; K A Sharp; B Honig
Journal:  Proteins       Date:  1991

Review 3.  Regulation of equine infectious anemia virus expression.

Authors:  W Maury
Journal:  J Biomed Sci       Date:  1998       Impact factor: 8.410

4.  Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus.

Authors:  R M Stephens; J W Casey; N R Rice
Journal:  Science       Date:  1986-02-07       Impact factor: 47.728

5.  Refined solution structure of p17, the HIV matrix protein.

Authors:  S Matthews; P Barlow; N Clark; S Kingsman; A Kingsman; I Campbell
Journal:  Biochem Soc Trans       Date:  1995-11       Impact factor: 5.407

6.  Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells.

Authors:  J W Wills; R C Craven; J A Achacoso
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

7.  1H-15N heteronuclear NMR studies of Escherichia coli thioredoxin in samples isotopically labeled by residue type.

Authors:  D M LeMaster; F M Richards
Journal:  Biochemistry       Date:  1985-12-03       Impact factor: 3.162

8.  Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly.

Authors:  C P Hill; D Worthylake; D P Bancroft; A M Christensen; W I Sundquist
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

9.  The three-dimensional solution structure of the matrix protein from the type D retrovirus, the Mason-Pfizer monkey virus, and implications for the morphology of retroviral assembly.

Authors:  M R Conte; M Klikova; E Hunter; T Ruml; S Matthews
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

10.  A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.

Authors:  M I Bukrinsky; S Haggerty; M P Dempsey; N Sharova; A Adzhubel; L Spitz; P Lewis; D Goldfarb; M Emerman; M Stevenson
Journal:  Nature       Date:  1993-10-14       Impact factor: 69.504

View more
  21 in total

1.  CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins.

Authors:  Chungwon Chung; Robert H Mealey; Travis C McGuire
Journal:  Virology       Date:  2004-09-15       Impact factor: 3.616

2.  Evolution of feline immunodeficiency virus Gag proteins.

Authors:  Evan Burkala; Mary Poss
Journal:  Virus Genes       Date:  2007-01-30       Impact factor: 2.332

3.  Surface features of a Mononegavirales matrix protein indicate sites of membrane interaction.

Authors:  Victoria A Money; Helen K McPhee; Jackie A Mosely; John M Sanderson; Robert P Yeo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-26       Impact factor: 11.205

4.  Rous sarcoma virus gag has no specific requirement for phosphatidylinositol-(4,5)-bisphosphate for plasma membrane association in vivo or for liposome interaction in vitro.

Authors:  Jany Chan; Robert A Dick; Volker M Vogt
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

5.  Specificity of plasma membrane targeting by the rous sarcoma virus gag protein.

Authors:  Lisa Z Scheifele; Jonathan D Rhoads; Leslie J Parent
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Structural and Mechanistic Studies of the Rare Myristoylation Signal of the Feline Immunodeficiency Virus.

Authors:  Janae B Brown; Holly R Summers; Lola A Brown; Jan Marchant; Paige N Canova; Colin T O'Hern; Sophia T Abbott; Constance Nyaunu; Simon Maxwell; Talayah Johnson; Morgan B Moser; Sherimay D Ablan; Hannah Carter; Eric O Freed; Michael F Summers
Journal:  J Mol Biol       Date:  2020-05-19       Impact factor: 5.469

7.  Solution properties of murine leukemia virus gag protein: differences from HIV-1 gag.

Authors:  Siddhartha A K Datta; Xiaobing Zuo; Patrick K Clark; Stephen J Campbell; Yun-Xing Wang; Alan Rein
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

8.  Oligomerization of a retroviral matrix protein is facilitated by backbone flexibility on nanosecond time scale.

Authors:  Pavel Srb; Jiří Vlach; Jan Prchal; Marián Grocký; Tomáš Ruml; Jan Lang; Richard Hrabal
Journal:  J Phys Chem B       Date:  2011-03-02       Impact factor: 2.991

9.  Phosphoinositides direct equine infectious anemia virus gag trafficking and release.

Authors:  Fiona Fernandes; Kang Chen; Lorna S Ehrlich; Jing Jin; Min H Chen; Gisselle N Medina; Marc Symons; Ronald Montelaro; Julie Donaldson; Nico Tjandra; Carol A Carter
Journal:  Traffic       Date:  2011-02-01       Impact factor: 6.215

10.  Myristate exposure in the human immunodeficiency virus type 1 matrix protein is modulated by pH.

Authors:  Emily L Fledderman; Ken Fujii; Ruba H Ghanam; Kayoko Waki; Peter E Prevelige; Eric O Freed; Jamil S Saad
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.